PRIALT may provide relief to patients with severe chronic pain--particularly pain that involves a neuropathic component, as well as for those who do not respond well to opioids or are unable to tolerate the adverse events associated with IT morphine.

At the 2007 meeting of the Polyanalgesic Consensus Panel, industry experts in interventional pain management identified PRIALT as a first-line alternative to morphine and hydromorphone for the IT infusion treatment for severe chronic pain.

The Elan Pain Information Center is a one-stop resource dedicated to providing the information you need or want to know about PRIALT. Get started today!
Visit  http://epic.prialt.com or call 1-888-PRIALT-1 (1-888-774-2581) for all the resources you need, all at your fingertips.

PRIALT is indicated for the management of severe chronic pain in patients for whom intrathecal (IT) therapy is warranted, and who are intolerant of or refractory to other treatment, such as systemic analgesics, adjunctive therapies or IT morphine.